Noel Bedwell, MD
Clinical Cardiac Electrophysiology · Mobile, ALNPI 1467433524
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $84 of the $94 with a category attached, or 88.5%. 4 manufacturers reported payments, led by Medtronic at 40.2% of the total. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in AL, where the typical reported total is $17,214.
Across 4 payments — averaging $23.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$38
- Abbott$25
- Boston Scientific$21
- Merck$11
Across 34 payments — averaging $5037.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim$130K
- Merck$20K
- Bayer$14K
- Boehringer Ingelheim Pharma GmbH & Co.kg$7K
- Boehringer Ingelheim Canada Ltd.ltee$503
- Boehringer Ingelheim France S.a.s.$355
What the payments were for
- Food & beverage$8489%
- Education$1111%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 1 | $38 |
| Abbott | 1 | $25 |
| Boston Scientific | 1 | $21 |
| Merck | 1 | $11 |
How this compares
$94 in reported general payments places this provider in the 0th percentile of 42 clinical cardiac electrophysiology providers in Alabama.
See all clinical cardiac electrophysiology providers in Alabama →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 421 | $445,851 |
| XareltoRivaroxaban | 121 | $137,195 |
| EntrestoSacubitril/Valsartan | 38 | $50,942 |
| MounjaroTirzepatide | 14 | $15,053 |
| Metoprolol Succinate | 535 | $7,048 |
| Diltiazem 24hr Er (La)Diltiazem Hcl | 58 | $5,972 |
| Potassium Chloride | 344 | $5,953 |
| Dabigatran EtexilateDabigatran Etexilate Mesylate | 12 | $3,920 |
| Amiodarone Hcl | 181 | $3,771 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 104 | $3,632 |
| Atorvastatin Calcium | 294 | $3,531 |
| Losartan Potassium | 254 | $3,470 |
| Flecainide Acetate | 33 | $2,820 |
| Rosuvastatin Calcium | 99 | $2,587 |
| Furosemide | 454 | $2,458 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Mobile
- Thomas TurnageMobile$71K
- Ernest QuinMobile$65K
- Jordan ChaissonMobile$46K
- Andin MullisMobile$42K
- Robert RobichauxMobile$20K
- Chance WittMobile$14K
- Stephanie GroszMobile$12K
- Hugh McElderryBirmingham$725K
- Anil RajendraBirmingham$495K
- Gustavo MoralesBirmingham$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.